The Clinical Outcomes of Imaging Modalities for Surgical Management Cushing's Disease - A Systematic Review and Meta-analysis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Jan 30

PMID 36714581

Authors

Chan Hee Koh

Danyal Z Khan

Ronneil Digpal

Hugo Layard Horsfall

Ahmad M S Ali

Stephanie E Baldeweg

Pierre-Marc Bouloux

Neil L Dorward

William M Drake

Jane Evanson

Joan Grieve

Danail Stoyanov

Marta Korbonits

Hani J Marcus

Affiliations

Soon will be listed here.

Abstract

Introduction: Cushing's disease presents major diagnostic and management challenges. Although numerous preoperative and intraoperative imaging modalities have been deployed, it is unclear whether these investigations have improved surgical outcomes. Our objective was to investigate whether advances in imaging improved outcomes for Cushing's disease.

Methods: Searches of PubMed and EMBASE were conducted. Studies reporting on imaging modalities and clinical outcomes after surgical management of Cushing's disease were included. Multilevel multivariable meta-regressions identified predictors of outcomes, adjusting for confounders and heterogeneity prior to investigating the effects of imaging.

Results: 166 non-controlled single-arm studies were included, comprising 13181 patients over 44 years.The overall remission rate was 77.0% [CI: 74.9%-79.0%]. Cavernous sinus invasion (OR: 0.21 [CI: 0.07-0.66]; p=0.010), radiologically undetectable lesions (OR: 0.50 [CI: 0.37-0.69]; p<0.0001), previous surgery (OR=0.48 [CI: 0.28-0.81]; p=0.008), and lesions ≥10mm (OR: 0.63 [CI: 0.35-1.14]; p=0.12) were associated with lower remission. Less stringent thresholds for remission was associated with higher reported remission (OR: 1.37 [CI: 1.1-1.72]; p=0.007). After adjusting for this heterogeneity, no imaging modality showed significant differences in remission compared to standard preoperative MRI.The overall recurrence rate was 14.5% [CI: 12.1%-17.1%]. Lesion ≥10mm was associated with greater recurrence (OR: 1.83 [CI: 1.13-2.96]; p=0.015), as was greater duration of follow-up (OR: 1.53 (CI: 1.17-2.01); p=0.002). No imaging modality was associated with significant differences in recurrence.Despite significant improvements in detection rates over four decades, there were no significant changes in the reported remission or recurrence rates.

Conclusion: A lack of controlled comparative studies makes it difficult to draw definitive conclusions. Within this limitation, the results suggest that despite improvements in radiological detection rates of Cushing's disease over the last four decades, there were no changes in clinical outcomes. Advances in imaging alone may be insufficient to improve surgical outcomes.

Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42020187751.

Citing Articles

Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement.

Newall N, Valetopoulou A, Khan D, Borg A, Bouloux P, Bremner F Pituitary. 2025; 28(2):36.

PMID: 40042764 PMC: 11882698. DOI: 10.1007/s11102-025-01502-7.

An integrated view of the pathophysiological crosstalk between adipose tissue, bone and cardiovascular system in men and women.

Klinaku F, Comi L, Giglione C, Magni P J Endocrinol Invest. 2024; .

PMID: 39692990 DOI: 10.1007/s40618-024-02516-x.

Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review.

Layard Horsfall H, Loh R, Venkatesh A, Khan D, Lawrence A, Jayapalan R Pituitary. 2023; 26(6):645-652.

PMID: 37843726 PMC: 10665258. DOI: 10.1007/s11102-023-01357-w.

References

Alexandraki K, Kaltsas G, Isidori A, Storr H, Afshar F, Sabin I . Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study. Eur J Endocrinol. 2013; 168(4):639-48. DOI: 10.1530/EJE-12-0921. View

Lindsay J, Oldfield E, Stratakis C, Nieman L . The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery. J Clin Endocrinol Metab. 2011; 96(7):2057-64. PMC: 3135190. DOI: 10.1210/jc.2011-0456. View

Ironside N, Chatain G, Asuzu D, Benzo S, Lodish M, Sharma S . Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease. Eur J Endocrinol. 2018; 178(3):255-263. PMC: 5812811. DOI: 10.1530/EJE-17-0873. View

Ghorbani M, Akbari H, Griessenauer C, Wipplinger C, Dastmalchi A, Malek M . Lateralization of inferior petrosal sinus sampling in Cushing's disease correlates with cavernous sinus venous drainage patterns, but not tumor lateralization. Heliyon. 2020; 6(10):e05299. PMC: 7586104. DOI: 10.1016/j.heliyon.2020.e05299. View

MacFarlane J, Bashari W, Senanayake R, Gillett D, van der Meulen M, Powlson A . Advances in the Imaging of Pituitary Tumors. Endocrinol Metab Clin North Am. 2020; 49(3):357-373. DOI: 10.1016/j.ecl.2020.06.002. View

Abu Dabrh A, Singh Ospina N, Al Nofal A, Farah W, Barrionuevo P, Sarigianni M . PREDICTORS OF BIOCHEMICAL REMISSION AND RECURRENCE AFTER SURGICAL AND RADIATION TREATMENTS OF CUSHING DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Endocr Pract. 2016; 22(4):466-75. DOI: 10.4158/EP15922.RA. View

Dai C, Fan Y, Liu X, Bao X, Yao Y, Wang R . Predictors of Immediate Remission after Surgery in Cushing's Disease Patients: A Large Retrospective Study from a Single Center. Neuroendocrinology. 2020; 111(11):1141-1150. DOI: 10.1159/000509221. View

Sagan K, Andrysiak-Mamos E, Sagan L, Nowacki P, Malkowski B, Syrenicz A . Cushing's Syndrome in a Patient With Rathke's Cleft Cyst and ACTH Cell Hyperplasia Detected by C-Methionine PET Imaging-A Case Presentation. Front Endocrinol (Lausanne). 2020; 11:460. PMC: 7388627. DOI: 10.3389/fendo.2020.00460. View

Pendharkar A, Sussman E, Ho A, Hayden Gephart M, Katznelson L . Cushing's disease: predicting long-term remission after surgical treatment. Neurosurg Focus. 2015; 38(2):E13. DOI: 10.3171/2014.10.FOCUS14682. View

10.

Vrieze S . Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Psychol Methods. 2012; 17(2):228-43. PMC: 3366160. DOI: 10.1037/a0027127. View

11.

Yap L, Turner H, Adams C, Wass J . Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Clin Endocrinol (Oxf). 2002; 56(1):25-31. DOI: 10.1046/j.0300-0664.2001.01444.x. View

12.

Truong H, Lieber S, Najera E, Alves-Belo J, Gardner P, Fernandez-Miranda J . The medial wall of the cavernous sinus. Part 1: Surgical anatomy, ligaments, and surgical technique for its mobilization and/or resection. J Neurosurg. 2018; 131(1):122-130. DOI: 10.3171/2018.3.JNS18596. View

13.

Stroud A, Dhaliwal P, Alvarado R, Winder M, Jonker B, Grayson J . Outcomes of pituitary surgery for Cushing's disease: a systematic review and meta-analysis. Pituitary. 2020; 23(5):595-609. DOI: 10.1007/s11102-020-01066-8. View

14.

Zaidi H, De Los Reyes K, Barkhoudarian G, Litvack Z, Bi W, Rincon-Torroella J . The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite. Neurosurg Focus. 2016; 40(3):E18. PMC: 4992957. DOI: 10.3171/2016.1.FOCUS15515. View

15.

Koulouri O, Steuwe A, Gillett D, Hoole A, Powlson A, Donnelly N . A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome. Eur J Endocrinol. 2015; 173(4):M107-20. DOI: 10.1530/EJE-15-0616. View

16.

Chandler W, Barkan A, Hollon T, Sakharova A, Sack J, Brahma B . Outcome of Transsphenoidal Surgery for Cushing Disease: A Single-Center Experience Over 32 Years. Neurosurgery. 2015; 78(2):216-23. DOI: 10.1227/NEU.0000000000001011. View

17.

Watson J, Shawker T, Nieman L, DeVroom H, Doppman J, Oldfield E . Localization of pituitary adenomas by using intraoperative ultrasound in patients with Cushing's disease and no demonstrable pituitary tumor on magnetic resonance imaging. J Neurosurg. 1998; 89(6):927-32. DOI: 10.3171/jns.1998.89.6.0927. View

18.

Liu Y, Liu X, Hong X, Liu P, Bao X, Yao Y . Prediction of Recurrence after Transsphenoidal Surgery for Cushing's Disease: The Use of Machine Learning Algorithms. Neuroendocrinology. 2019; 108(3):201-210. DOI: 10.1159/000496753. View

19.

Lonser R, Nieman L, Oldfield E . Cushing's disease: pathobiology, diagnosis, and management. J Neurosurg. 2016; 126(2):404-417. DOI: 10.3171/2016.1.JNS152119. View

20.

Brooke B, Schwartz T, Pawlik T . MOOSE Reporting Guidelines for Meta-analyses of Observational Studies. JAMA Surg. 2021; 156(8):787-788. DOI: 10.1001/jamasurg.2021.0522. View